Amarante I, Faustino C, Mota B, Cascais M, Almeida J, Valentim M. Full recovery over one year of the overlap syndrome scleromyositis to maintenance therapy with mycophenolate mofetil and rituximab, which relapsed within 8 months of discontinuation. EJCRIM [Internet]. 2025 May 5 [cited 2026 Nov. 3];12(5). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5154